REQUEST A DEMO
Total
USD $0.00
Search more companies

Biocoll Pharmaceuticals Private Limited (India)

Main Activities: Other Business Support Services
Full name: Biocoll Pharmaceuticals Private Limited Profile Updated: March 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Biocoll Pharmaceuticals Private Limited is a company in India, with a head office in North West Delhi. It operates in the Other Business Support Services industry. It was established on April 18, 2015. In its most recent financial highlights, the company reported a net sales revenue increase of 58.01% in 2025. Over the same period, its total assets grew by 68.36%. Biocoll Pharmaceuticals Private Limited’s net profit margin increased by 1.88% in 2025.

Legal Address
House No. 821, Gali No. 50 Lekhu Nagar, Tri Nagar
North West Delhi; Delhi; Postal Code: 110035

Contact Details: Purchase the Biocoll Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Biocoll Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Biocoll Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
April 18, 2015
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Biocoll Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
58.01%
Total Operating Revenue
58.01%
Operating Profit
244.78%
EBITDA
242.32%
Net Profit/Loss for the Period
242.42%
Total Assets
68.36%
Total Equity
84.09%
Operating Profit Margin
2.03%
Net Profit Margin
1.88%
Return on Equity (ROE)
21.24%
Debt / Equity
-48%
Quick Ratio
-0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?